Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-24-049432
Filing Date
2024-12-13
Accepted
2024-12-13 16:11:11
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 ny20039376x3_s3.htm S-3 422120
2 EXHIBIT 5.1 ny20039376x3_ex5-1.htm EX-5.1 7423
3 EXHIBIT 23.2 ny20039376x3_ex23-2.htm EX-23.2 2143
4 EXHIBIT 23.3 ny20039376x3_ex23-3.htm EX-23.3 2730
5 EXHIBIT 107 ny20039376x3_ex107.htm EX-FILING FEES 44767
6 logo_cartesian.jpg GRAPHIC 51818
7 ny20039376x3_ex5-1logo01.jpg GRAPHIC 9895
8 ny20039376x3_ex5-1logo02.jpg GRAPHIC 2062
  Complete submission text file 0001140361-24-049432.txt   568254
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283806 | Film No.: 241548446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)